Comparison of letrozole and Cetrolix acetate in the prevention of ovarian hyperstimulation syndrome
Phase 3
- Conditions
- Ovarian Hyperstimulation Syndrom.Hyperstimulation of ovariesN98.1
- Registration Number
- IRCT20240627062268N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 110
Inclusion Criteria
Age of 20 to 35 years old
BMI 18 to 29 kg/m2
AMH level more than 4ng/ml
The number of antral follicles (AFC) in each ovary more than 12, confirmed by transvaginal ultrasound
Serum level of estradiol (E2) more than 4000 pg/ml on the trigger day
The number of punctured follicles more than 15 per ovary (follicular diameter of 14 mm on the day of egg retrieval)
Exclusion Criteria
Contraindications for use of letrozole or cetrolix acetate include severe liver and kidney dysfunction
Women with estradiol (E2) level less than 4000 pg/ml in trigger day
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method